ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 592,28
-0,53%
Dow Jones
40 211,72
0,53%
DAX
18 524,49
-0,41%
Brent Oil
83,685
-0,78%
Bitcoin
63 183,83
-2,57%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
23/03/202113h30InvestorsHub NewsWireAPYP New Apnea AI Solution Could Disrupt $3.7B Sleeping Disorder MarketNYSE:TEVATeva Pharmaceutical Industries Ltd
17/03/202121h03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:TEVATeva Pharmaceutical Industries Ltd
08/03/202120h46Business WireTeva Announces Launch of First Generic Version of AZOPT® (brinzolamide ophthalmic suspension) 1%, used to treat high pressur...NYSE:TEVATeva Pharmaceutical Industries Ltd
04/03/202112h19Dow Jones NewsEuropean Commission Opens Antitrust Investigation Against Teva Over Multiple-Sclerosis DrugNYSE:TEVATeva Pharmaceutical Industries Ltd
01/03/202122h00Business WireTeva to Present at the J.P. Morgan 2021 Global High Yield and Leveraged Finance ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
26/02/202114h00Business WireNew Study Published in Cephalalgia Identifies Mechanistic Differences Among CGRP Migraine TreatmentsNYSE:TEVATeva Pharmaceutical Industries Ltd
17/02/202122h12Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NYSE:TEVATeva Pharmaceutical Industries Ltd
16/02/202121h59Edgar (US Regulatory)Schedule 13gNYSE:TEVATeva Pharmaceutical Industries Ltd
10/02/202122h07Edgar (US Regulatory)Annual Report (10-k)NYSE:TEVATeva Pharmaceutical Industries Ltd
10/02/202113h01Edgar (US Regulatory)Current Report Filing (8-k)NYSE:TEVATeva Pharmaceutical Industries Ltd
10/02/202113h00Business WireTeva Reports Fourth Quarter and Full Year 2020 Financial ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
14/01/202123h17Business WireTeva Announces Launch of a Generic Version of NuvaRing® (etonogestrel and ethinyl estradiol) Vaginal Ring in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
08/01/202121h07Dow Jones NewsCorrection to Drugmakers Raise Prices Article of Jan. 1NYSE:TEVATeva Pharmaceutical Industries Ltd
08/01/202121h01Business WireTeva to Host Conference Call to Discuss Fourth Quarter 2020 Financial Results & 2021 Financial Guidance at 8 a.m. ET on Febru...NYSE:TEVATeva Pharmaceutical Industries Ltd
07/01/202122h00Business WireTeva to Present at the 39th Annual J.P. Morgan Healthcare ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
07/01/202115h12Dow Jones NewsTeva, MedinCell Say Results Positive in Risperidone TrialNYSE:TEVATeva Pharmaceutical Industries Ltd
07/01/202114h00Business WireTeva & MedinCell Announce Positive Results for Registration Trial of Investigational Extended-Release Subcutaneous Injectable...NYSE:TEVATeva Pharmaceutical Industries Ltd
26/11/202013h52Dow Jones NewsEuropean Commission Fines Teva, Cephalon EUR60.5 Million for Antitrust ViolationNYSE:TEVATeva Pharmaceutical Industries Ltd
05/11/202013h00Business WireTeva Reports Third Quarter 2020 Financial ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
21/10/202014h00Business WireTeva, Amazon Web Services and Onica Announce Collaboration to Support Teva’s Digihaler® PortfolioNYSE:TEVATeva Pharmaceutical Industries Ltd
19/10/202009h14Dow Jones NewsShield Therapeutics: Peer Teva Pharmaceutical Industries Withdraws Oppositions to PatentsNYSE:TEVATeva Pharmaceutical Industries Ltd
15/10/202013h30GlobeNewswire Inc.iBio Announces Appointment of Dr. Alexandra Kropotova to Board of DirectorsNYSE:TEVATeva Pharmaceutical Industries Ltd
07/10/202014h00Business WireTeva Announces New Analysis of Consistency in Migraine Days Over the Course of a Dosing Regimen for AJOVY® (fremanezumab-vfr...NYSE:TEVATeva Pharmaceutical Industries Ltd
05/10/202014h00PR Newswire (Canada)Teva Canada announces availability of Aermony RespiClick™, an innovative new device for the treatment of bronchial asthmaNYSE:TEVATeva Pharmaceutical Industries Ltd
05/10/202014h00PR Newswire (Canada)Teva Canada annonce la mise en marché d'Aermony RespiClickMC, un nouveau dispositif novateur dans le traitement de l'asthme ...NYSE:TEVATeva Pharmaceutical Industries Ltd
05/10/202014h00Business WireTeva Canada annonce la mise en marché d’Aermony RespiClickMC, un nouveau dispositif novateur dans le traitement de l’ast...NYSE:TEVATeva Pharmaceutical Industries Ltd
02/10/202014h00Business WireTeva Launches First Generic Versions of HIV-1 Treatments TRUVADA® (emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg...NYSE:TEVATeva Pharmaceutical Industries Ltd
01/10/202017h06Business WireTeva to Host Conference Call to Discuss Third Quarter 2020 Financial Results at 8 a.m. ET on November 5, 2020NYSE:TEVATeva Pharmaceutical Industries Ltd
21/09/202014h00Business WireTeva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate & salmeterol) Inhalation Powder ...NYSE:TEVATeva Pharmaceutical Industries Ltd
15/09/202014h00Business WireFirst Long-Term Data on the use of AJOVY® (fremanezumab-vfrm) Injection in Patients with Migraine Published in NeurologyNYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

EU
ML
Michelin
EU
CS
Axa
EU
AF
Air FranceKLM
EU
MC
Lvmh Moet Hennessy Louis...
NYSE
JPM
JP Morgan Chase
SPI
SP500
S&P 500
EU
RNO
Renault
EU
VIV
Vivendi
FTSE
UKX
FTSE 100
EU
GLE
Societe Generale
NYSE
DIS
Walt Disney
NASDAQ
AAPL
Apple
EU
EN
Bouygues
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés